🍽️ lactobacillus sakei (probiotics)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of lactobacillus sakei (probiotics) On Probiotics

Rank Probiotic Impact
species Bifidobacterium adolescentis Increases
species Bifidobacterium bifidum Increases
species Bifidobacterium breve Increases
species Bifidobacterium catenulatum Increases
species Bifidobacterium longum Increases
species Bifidobacterium pseudocatenulatum Increases

Bacteria Impacted by lactobacillus sakei (probiotics)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Terrabacteria group clade Decreases 👪 Source Study
Terrabacteria group clade Increases 👪 Source Study
Clostridia class Decreases 📓 Source Study
Bacilli class Decreases 👶 Source Study
Clostridia class Decreases 👶 Source Study
Desulfuribacillia class Decreases 👶 Source Study
Dethiobacteria class Decreases 👶 Source Study
Erysipelotrichia class Decreases 👶 Source Study
Limnochordia class Decreases 👶 Source Study
Negativicutes class Decreases 👶 Source Study
Thermolithobacteria class Decreases 👶 Source Study
Tissierellia class Decreases 👶 Source Study
Acidimicrobiia class Increases 👶 Source Study
Actinomycetes class Increases 👶 Source Study
Coriobacteriia class Increases 👶 Source Study
Nitriliruptoria class Increases 👶 Source Study
Rubrobacteria class Increases 👶 Source Study
Thermoleophilia class Increases 👶 Source Study
Alphaproteobacteria class Increases 📓 Source Study
Bacteroidia class Increases 📓 Source Study
Betaproteobacteria class Increases 📓 Source Study
Fusobacteriia class Increases 📓 Source Study
Enterobacteriaceae family Decreases 📓 Source Study
Bifidobacteriaceae family Increases 👪 Source Study
Prevotellaceae family Increases 👪 Source Study
Bacteroides genus Decreases 📓 Source Study
Bacteroides genus Decreases 📓 Source Study
Bifidobacterium genus Increases 📓 Source Study
Bifidobacterium genus Increases 📓 Source Study
Lactobacillus genus Increases 📓 Source Study Pathogen
Prevotella genus Increases 📓 Source Study
Bacillota sensu stricto incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Bacillota no rank Decreases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Actinomycetota no rank Increases 👶 Source Study
unclassified Bifidobacterium no rank Increases 👶 Source Study
unclassified Prevotella no rank Increases 👶 Source Study
Bacillota phylum Decreases 📓 Source Study
Actinomycetota phylum Increases 📓 Source Study
Actinomycetota phylum Increases 📓 Source Study
Campylobacterota phylum Increases 📓 Source Study
Fusobacteriota phylum Increases 📓 Source Study
Bifidobacterium actinocoloniiforme species Increases 👶 Source Study
Bifidobacterium adolescentis species Increases 👶 Source Study
Bifidobacterium aesculapii species Increases 👶 Source Study
Bifidobacterium angulatum species Increases 👶 Source Study
Bifidobacterium animalis species Increases 👶 Source Study
Bifidobacterium asteroides species Increases 👶 Source Study
Bifidobacterium avesanii species Increases 👶 Source Study
Bifidobacterium biavatii species Increases 👶 Source Study
Bifidobacterium bifidum species Increases 👶 Source Study
Bifidobacterium bohemicum species Increases 👶 Source Study
Bifidobacterium bombi species Increases 👶 Source Study
Bifidobacterium boum species Increases 👶 Source Study
Bifidobacterium breve species Increases 👶 Source Study
Bifidobacterium callitrichidarum species Increases 👶 Source Study
Bifidobacterium callitrichos species Increases 👶 Source Study
Bifidobacterium catenulatum species Increases 👶 Source Study
Bifidobacterium choerinum species Increases 👶 Source Study
Bifidobacterium commune species Increases 👶 Source Study
Bifidobacterium coryneforme species Increases 👶 Source Study
Bifidobacterium cuniculi species Increases 👶 Source Study
Bifidobacterium dentium species Increases 👶 Source Study
Bifidobacterium eulemuris species Increases 👶 Source Study
Bifidobacterium faecale species Increases 👶 Source Study
Bifidobacterium gallicum species Increases 👶 Source Study
Bifidobacterium imperatoris species Increases 👶 Source Study
Bifidobacterium indicum species Increases 👶 Source Study
Bifidobacterium lemurum species Increases 👶 Source Study
Bifidobacterium longum species Increases 👶 Source Study
Bifidobacterium magnum species Increases 👶 Source Study
Bifidobacterium merycicum species Increases 👶 Source Study
Bifidobacterium minimum species Increases 👶 Source Study
Bifidobacterium mongoliense species Increases 👶 Source Study
Bifidobacterium moukalabense species Increases 👶 Source Study
Bifidobacterium myosotis species Increases 👶 Source Study
Bifidobacterium porcinum species Increases 👶 Source Study
Bifidobacterium pseudocatenulatum species Increases 👶 Source Study
Bifidobacterium pseudolongum species Increases 👶 Source Study
Bifidobacterium psychraerophilum species Increases 👶 Source Study
Bifidobacterium pullorum species Increases 👶 Source Study
Bifidobacterium reuteri species Increases 👶 Source Study
Bifidobacterium ruminantium species Increases 👶 Source Study
Bifidobacterium saguini species Increases 👶 Source Study
Bifidobacterium scardovii species Increases 👶 Source Study
Bifidobacterium stellenboschense species Increases 👶 Source Study
Bifidobacterium stercoris species Increases 👶 Source Study
Bifidobacterium subtile species Increases 👶 Source Study
Bifidobacterium thermacidophilum species Increases 👶 Source Study
Bifidobacterium thermophilum species Increases 👶 Source Study
Bifidobacterium tissieri species Increases 👶 Source Study
Bifidobacterium tsurumiense species Increases 👶 Source Study
Prevotella amnii species Increases 👶 Source Study
Prevotella aurantiaca species Increases 👶 Source Study
Prevotella bivia species Increases 👶 Source Study Infectious bacteria
Prevotella brevis species Increases 👶 Source Study
Prevotella conceptionensis species Increases 👶 Source Study
Prevotella corporis species Increases 👶 Source Study
Prevotella dentalis species Increases 👶 Source Study
Prevotella dentasini species Increases 👶 Source Study
Prevotella denticola species Increases 👶 Source Study
Prevotella disiens species Increases 👶 Source Study
Prevotella falsenii species Increases 👶 Source Study
Prevotella fusca species Increases 👶 Source Study
Prevotella herbatica species Increases 👶 Source Study
Prevotella histicola species Increases 👶 Source Study
Prevotella intermedia species Increases 👶 Source Study Infectious bacteria
Prevotella jejuni species Increases 👶 Source Study
Prevotella marseillensis species Increases 👶 Source Study
Prevotella melaninogenica species Increases 👶 Source Study Pathogen
Prevotella merdae species Increases 👶 Source Study
Prevotella micans species Increases 👶 Source Study
Prevotella multiformis species Increases 👶 Source Study
Prevotella nigrescens species Increases 👶 Source Study
Prevotella oryzae species Increases 👶 Source Study
Prevotella pallens species Increases 👶 Source Study
Prevotella pectinovora species Increases 👶 Source Study
Prevotella phocaeensis species Increases 👶 Source Study
Prevotella rara species Increases 👶 Source Study
Prevotella ruminicola species Increases 👶 Source Study
Prevotella scopos species Increases 👶 Source Study
Prevotella sp. P5-119 species Increases 👶 Source Study
Prevotella veroralis species Increases 👶 Source Study

Impact of lactobacillus sakei (probiotics) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 -0.6
Acne 2.3 1.4 0.64
ADHD 0.9 3.5 -2.89
Allergic Rhinitis (Hay Fever) 3.1 0.6 4.17
Allergies 2.5 2.8 -0.12
Allergy to milk products 1.7 1.7 0
Alopecia (Hair Loss) 0.5 0.5
Alzheimer's disease 3.1 4.2 -0.35
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.5 3.1 -5.2
Ankylosing spondylitis 2.2 3.8 -0.73
Anorexia Nervosa 0.7 1.4 -1
Asthma 0.8 2.4 -2
Atherosclerosis 0.6 2.4 -3
Atrial fibrillation 1.7 1.7 0
Autism 6.2 5.1 0.22
Bipolar Disorder 1.6 3.1 -0.94
Brain Trauma 2 1.4 0.43
Carcinoma 1.1 1.7 -0.55
Celiac Disease 4.6 2.3 1
Cerebral Palsy 0.6 1.7 -1.83
Chronic Fatigue Syndrome 1.9 2.8 -0.47
Chronic Kidney Disease 1.1 1.1 0
Chronic Lyme 0.5 0.5 0
Chronic Obstructive Pulmonary Disease (COPD) 0.6 -0.6
Chronic Urticaria (Hives) 1.2 0.8 0.5
Coagulation / Micro clot triggering bacteria 0.3 0.3
Colorectal Cancer 1.9 3 -0.58
Constipation 2.1 2.1
Coronary artery disease 0.6 -0.6
COVID-19 6.8 6.6 0.03
Crohn's Disease 3.3 3.9 -0.18
cystic fibrosis 0.6 1.1 -0.83
Depression 6 5.4 0.11
Dermatomyositis 0.6 1.1 -0.83
Eczema 1.4 0.6 1.33
Endometriosis 2.1 2 0.05
Eosinophilic Esophagitis 1.4 -1.4
Epilepsy 3.4 4 -0.18
Fibromyalgia 1.2 0.5 1.4
Functional constipation / chronic idiopathic constipation 3.8 3 0.27
gallstone disease (gsd) 0.6 0.6
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.1 1.8 -0.64
Generalized anxiety disorder 0.8 0.5 0.6
Glioblastoma 0.6 0.6
Gout 0.3 0.6 -1
Graves' disease 0.7 5 -6.14
Halitosis 0.5 0.6 -0.2
Hashimoto's thyroiditis 1.7 1.1 0.55
Heart Failure 0.2 0.2
Hidradenitis Suppurativa 1.1 -1.1
Histamine Issues,Mast Cell Issue, DAO Insufficiency 0.8 0.6 0.33
hypercholesterolemia (High Cholesterol) 0.6 -0.6
hyperglycemia 1.2 0.5 1.4
Hyperlipidemia (High Blood Fats) 1.8 2 -0.11
hypersomnia 0.2 0.2
hypertension (High Blood Pressure 2.9 2.9 0
Hypothyroidism 1.2 0.2 5
Hypoxia 1.1 0.6 0.83
IgA nephropathy (IgAN) 2.3 2.3
Inflammatory Bowel Disease 2.4 4.6 -0.92
Insomnia 1.1 2.9 -1.64
Intelligence 0.9 0.9
Intracranial aneurysms 2.3 2.3
Irritable Bowel Syndrome 3.7 3.4 0.09
Juvenile idiopathic arthritis 1.7 -1.7
Liver Cirrhosis 2.8 2.3 0.22
Long COVID 4.7 6.2 -0.32
Lung Cancer 0.3 -0.3
ME/CFS with IBS 0.6 0.5 0.2
ME/CFS without IBS 0.6 0.5 0.2
Menopause 0.2 0.4 -1
Metabolic Syndrome 4.9 5.3 -0.08
Mood Disorders 6.6 7.6 -0.15
multiple chemical sensitivity [MCS] 0.6 -0.6
Multiple Sclerosis 2.1 4 -0.9
Multiple system atrophy (MSA) 0.8 0.6 0.33
myasthenia gravis 0.5 -0.5
Neuropathy (all types) 1.1 1.2 -0.09
neuropsychiatric disorders (PANDAS, PANS) 0.5 -0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.5 2.9 0.21
NonCeliac Gluten Sensitivity 0.6 0.6
Obesity 3.7 4.7 -0.27
obsessive-compulsive disorder 3 0.5 5
Osteoarthritis 0.7 0.5 0.4
Osteoporosis 1.7 2.5 -0.47
Parkinson's Disease 3 3.1 -0.03
Polycystic ovary syndrome 1.6 1.5 0.07
Postural orthostatic tachycardia syndrome 1.1 1.1
Premenstrual dysphoric disorder 0.6 0.6 0
primary biliary cholangitis 0.2 -0.2
Psoriasis 2 3.1 -0.55
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3 4.8 -0.6
Rosacea 0.6 2.5 -3.17
Schizophrenia 3.1 4.9 -0.58
scoliosis 0.6 0.6
Sjögren syndrome 2.7 1.1 1.45
Sleep Apnea 1.8 1.1 0.64
Small Intestinal Bacterial Overgrowth (SIBO) 0.7 1.1 -0.57
Stress / posttraumatic stress disorder 2.4 2.2 0.09
Systemic Lupus Erythematosus 5.3 2.3 1.3
Tic Disorder 1.5 0.6 1.5
Tourette syndrome 0.6 0.5 0.2
Type 1 Diabetes 2.6 2.1 0.24
Type 2 Diabetes 4.3 5.3 -0.23
Ulcerative colitis 4.2 5 -0.19
Unhealthy Ageing 2.2 0.6 2.67

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)